Information updates

Changes to Medicare-funded allergy testing - effective 1 November 2018

5 May 2018

The Australian Government is making changes to Medicare-funded dermatology, allergy and immunology services, following recommendations from the Medicare Benefits Schedule (MBS) Review Taskforce.

New restrictions on allergen testing will be introduced on 1 November 2018 to discourage testing for more than 20 allergens at a time. Allergen testing items will further be restructured into tests for environmental, food and latex, medication, and anaesthetic-related allergies. For more information go to http://health.gov.au/internet/main/publishing.nsf/Content/MBSR-Safe-and-best-practice-dermatology-allergy-and-immunology-services

The Australasian Society of Clinical Immunology and Allergy (ASCIA) made a detailed submission to the MBS Review Taskforce in July 2017 which outlined concerns about the proposed restrictions, particularly regarding the potential effects on diagnosing patients with complex allergic diseases.  The ASCIA submission also noted that it is likely that the increased use of skin testing reflects the epidemiology of allergic disease, with well-documented significant increases in disease prevalence (greater than the rate of population rise) in recent years. Skin prick testing is the primary diagnostic mode in allergic disease and offers the most cost-effective method to identify allergic sensitisation.  Whilst receipt of this submission was acknowledged, ASCIA was not consulted further about the proposed restrictions, despite requests.

 

Content updated 5 May 2018

Mod ASCIA Member
Donate to AIFA
go to NAS website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information.Verify here.